Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.80ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.80ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
XBB.1.5.80NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.37.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.37.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used